Stock Track | Phreesia Soars 6.01% as Strong Q3 Results and Upbeat Guidance Fuel Optimism

Stock Track12-10

Shares of Phreesia, Inc. (NYSE: PHR), a leading healthcare technology company, soared 6.01% intraday on Tuesday, December 10, 2024, following the company's impressive third-quarter fiscal 2025 results and an optimistic outlook for the upcoming fiscal year.

Phreesia reported a 17% year-over-year increase in revenue to $106.8 million for the third quarter ended October 31, 2024. The company also achieved positive adjusted EBITDA of $9.8 million, a significant improvement of $16.4 million compared to the prior year. Encouraged by the strong performance, Phreesia raised its fiscal 2025 adjusted EBITDA guidance to a range of $34 million to $36 million, up from the previous range of $26 million to $31 million.

Looking ahead, the company provided an optimistic outlook for fiscal 2026, expecting revenue to grow by 13% to 15% and adjusted EBITDA to increase by a staggering 129% to 144% compared to fiscal 2025. These positive projections further fueled investor optimism and contributed to the stock's surge.

The solid third-quarter results, raised guidance for the current fiscal year, and robust outlook for fiscal 2026 indicate Phreesia's strong momentum and growth trajectory. Investors responded favorably to the company's impressive performance and upbeat expectations, driving the stock's significant intraday gain.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment